Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer

Chan, 2010, Nasopharyngeal cancer: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 21, v187, 10.1093/annonc/mdq186 National Cancer Intelligence Network, 2002 Pow, 2006, Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial, Int J Radiat Oncol Biol Phys, 66, 981, 10.1016/j.ijrobp.2006.06.013 Kam, 2007, Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients, J Clin Oncol, 25, 4873, 10.1200/JCO.2007.11.5501 American Joint Committee on Cancer, 1997 Cox, 1995, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), Int J Radiat Oncol Biol Phys, 31, 1341, 10.1016/0360-3016(95)00060-C Nutting, 2011, Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, Lancet Oncol, 12, 127, 10.1016/S1470-2045(10)70290-4 National Institute of Health. Common Terminology Criteria for Adverse Events v3.0. Rubin, 1995, EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system, Radiother Oncol, 35, 9, 10.1016/0167-8140(95)97447-L Bentzen, 1994, Radiobiological considerations in the design of clinical trials, Radiother Oncol, 32, 1, 10.1016/0167-8140(94)90443-X Colaco, 2013, Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre, Clin Oncol (R Coll Radiol), 25, 171, 10.1016/j.clon.2012.10.006 Lee, 2002, Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience, Int J Radiat Oncol Biol Phys, 53, 12, 10.1016/S0360-3016(02)02724-4 Zhao, 2012, Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China, Oral Oncol, 48, 864, 10.1016/j.oraloncology.2012.03.001 Wu, 2013, Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy, Head Neck, 35, 689, 10.1002/hed.23010 Gulliford, 2012, Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT phase III trial, Radiother Oncol, 104, 205, 10.1016/j.radonc.2012.07.005 Powell, 2014, Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain, Radiother Oncol, 110, 416, 10.1016/j.radonc.2013.06.042 Lee, 2007, Nasopharyngeal cancer: advances in radiotherapy, Int J Radiat Oncol Biol Phys, 69, S115, 10.1016/j.ijrobp.2007.05.042 Bhide, 2007, Otological toxicity after postoperative radiotherapy for parotid tumours, Clin Oncol (R Coll Radiol), 19, 77, 10.1016/j.clon.2006.11.007 Wolden, 2006, Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience, Int J Radiat Oncol Biol Phys, 64, 57, 10.1016/j.ijrobp.2005.03.057 Kwong, 2006, Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma, Int J Radiat Oncol Biol Phys, 64, 374, 10.1016/j.ijrobp.2005.07.968 Kam, 2004, Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience, Int J Radiat Oncol Biol Phys, 60, 1440, 10.1016/j.ijrobp.2004.05.022 Lin, 2010, Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases, BMC Cancer, 10, 39, 10.1186/1471-2407-10-39